Traub W H, Spohr M, Bauer D
Institut für Medizinische Mikrobiologie und Hygiene, Universität des Saarlandes Homburg a.d. Saar, BRD.
Chemotherapy. 1991;37(3):186-95. doi: 10.1159/000238852.
Neither teicoplanin nor vancomycin at 2, 1 and 0.5 micrograms/ml consistently killed inocula of representative isolates of a multiple-drug-resistant (MDR) strain of Staphylococcus aureus in the presence of 65% (v/v) of fresh, defibrinated human blood, although both antibiotics sterilized tube contents in Mueller-Hinton broth (MHB). With added human blood, teicoplanin (1 microgram/ml) combined with rifampin (1 microgram/ml) was the most effective in vitro combination, followed by teicoplanin (1 microgram/ml) + amoxicillin (8 micrograms/ml) + clavulanate (3 micrograms/ml), ampicillin (8 micrograms/ml) + sulbactam (8 micrograms/ml), cefamandole (8 micrograms/ml), fosfomycin (4 micrograms/ml + 25 micrograms/ml glucose-6-phosphate), imipenem (8 micrograms/ml), netilmicin (4 micrograms/ml), trimethoprim + sulfamethoxazole (1/19 micrograms/ml) and vancomycin (1 microgram/ml), respectively. Conversely, teicoplanin (1 microgram/ml) combined with fusidic acid (0.5 micrograms/ml) and ofloxacin (4 micrograms/ml), respectively, proved ineffective with 65% (v/v) added human blood. In concurrent control tubes, however, all drug combinations were bactericidally active in MHB against the MDR strain of S. aureus.
在含有65%(v/v)新鲜去纤维蛋白人血的情况下,替考拉宁和万古霉素在2、1和0.5微克/毫升浓度时均不能持续杀灭多重耐药(MDR)金黄色葡萄球菌代表性分离株的接种物,尽管这两种抗生素在 Mueller-Hinton肉汤(MHB)中能使试管内容物达到无菌状态。添加人血后,替考拉宁(1微克/毫升)与利福平(1微克/毫升)联合使用是最有效的体外联合用药,其次是替考拉宁(1微克/毫升)+阿莫西林(8微克/毫升)+克拉维酸(3微克/毫升)、氨苄西林(8微克/毫升)+舒巴坦(8微克/毫升)、头孢孟多(8微克/毫升)、磷霉素(4微克/毫升+25微克/毫升葡萄糖-6-磷酸)、亚胺培南(8微克/毫升)、奈替米星(4微克/毫升)、甲氧苄啶+磺胺甲恶唑(1/19微克/毫升)和万古霉素(1微克/毫升)。相反,替考拉宁(1微克/毫升)分别与夫西地酸(0.5微克/毫升)和氧氟沙星(4微克/毫升)联合使用,在添加65%(v/v)人血时被证明无效。然而,在同时设置的对照试管中,所有药物组合在MHB中对MDR金黄色葡萄球菌菌株均具有杀菌活性。